Ftse Mib
33.787,00
0,00%
DAX
19.969,86
-1,44%
S&P 500
5.867,08
-0,09%
NASDAQ
19.372,77
-0,10%
Bitcoin
96.745,40
-0,73%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lifecore Biomedical Inc (LFCR) Lifecore Biomedical Inc (LFCR) Notizie

Lifecore Biomedical Inc

LFCR
7,07
0,13 (1,87%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202422:05GLOBELifecore Biomedical to Report Financial Results for Second..
19/12/202413:00GLOBELifecore Biomedical Selected by Nirsum Labs to Provide CDMO..
10/12/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202423:29EDGAR2Form 8-K - Current report
26/11/202422:05GLOBELifecore Biomedical Amends and Extends Revolving Credit..
21/11/202422:17GLOBELifecore Biomedical Hosts Virtual Investor Day
21/11/202413:55EDGAR2Form 8-K - Current report
20/11/202416:14EDGAR2Form 144 - Report of proposed sale of securities
12/11/202422:05GLOBELifecore Biomedical to Present at Stephens Annual Investment..
12/11/202420:43EDGAR2Form 144 - Report of proposed sale of securities
08/11/202422:32EDGAR2Form 8-K - Current report
07/11/202413:00GLOBELifecore Biomedical to Host Virtual Investor Day Prior to..
04/11/202413:00GLOBELifecore Biomedical Appoints Thomas Guldager as Vice..
31/10/202421:18EDGAR2Form 144 - Report of proposed sale of securities
29/10/202421:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202422:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/10/202422:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202422:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202422:37EDGAR2Form S-1 - General form for registration of securities under..
10/10/202422:36EDGAR2Form POS AM - Post-Effective amendments for registration..
07/10/202419:03EDGAR2Form 144 - Report of proposed sale of securities
04/10/202413:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/10/202413:36EDGAR2Form 8-K - Current report
04/10/202413:30GLOBELifecore Biomedical Reports First Quarter of Fiscal 2025..
04/10/202413:20GLOBELifecore Biomedical Raises $24.3 Million in Private..
03/10/202422:05GLOBELifecore Biomedical to Report Financial Results for First..
01/10/202413:00GLOBELifecore Biomedical Selected by Lindy Biosciences to Support..
25/9/202422:05GLOBELifecore Biomedical to Participate at Upcoming Industry..
23/9/202422:21EDGAR2Form DEF 14A - Other definitive proxy statements
23/9/202422:14EDGAR2Form 8-K - Current report
20/9/202422:00EDGAR2Form 144 - Report of proposed sale of securities
19/9/202413:00GLOBELifecore Biomedical Announces High-Speed, Multi-Purpose..
12/9/202422:05GLOBELifecore Biomedical to Participate in Craig-Hallum..
12/9/202413:09EDGAR2Form 8-K - Current report
12/9/202413:00GLOBELifecore Biomedical Regains Compliance with Nasdaq Listing..
10/9/202413:00GLOBELifecore Biomedical Appoints Brikkelle Thompson as Senior..
06/9/202422:05GLOBELifecore Biomedical Announces Inducement Grants Under Nasdaq..
05/9/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:05GLOBELifecore Biomedical to Participate in 17th Annual Barrington..
05/9/202417:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/8/202422:03EDGAR2Form 8-K - Current report
29/8/202413:00GLOBELifecore Biomedical Announces Chief Financial Officer..
26/8/202423:26EDGAR2Form 8-K - Current report
26/8/202423:23GLOBELifecore Biomedical Reports Fourth Quarter and Fiscal Year..
26/8/202422:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/8/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202420:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/8/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 7,035 Min: 6,87 Max: 7,16
Chiusura: 6,94

La tua Cronologia

NASDAQ
LFCR
Lifecore Biomedical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network